临床荟萃

• 论著 • 上一篇    下一篇

钙结合蛋白S100A12水平与慢性阻塞性肺疾病急性加重期患者严重程度的相关性

  

  1. 1.甘肃中医药大学 临床医学院,甘肃 兰州  730000;  2.甘肃省人民医院 呼吸科,甘肃 兰州  730000; 
    3.宁夏医科大学 临床医学院,宁夏 银川  750000
  • 出版日期:2018-02-05 发布日期:2018-02-11
  • 通讯作者: 通信作者:刘华,Email:13919965016@163.com

Correlation between calciumbinding protein  S100A12 level and severity of patients with chronic obstructive pulmonary disease in acute exacerbation

  1. 1.Clinical Medical College, Gansu University of Traditional Chinese Medicine, Lanzhou  730000, China;
    2.Department of Respiratory Medicine, Gansu Province People’s of Hospital, Lanzhou 730000, China;
    3.Clinical Medical College, Ningxia Medical University, Yinchuan 750000, China
  • Online:2018-02-05 Published:2018-02-11
  • Contact: Corresponding author:Liu Hua, Email:13919965016@163.com

摘要: 目的  探讨血清钙结合蛋白S100A12水平与慢性阻塞性肺疾病急性加重期(AECOPD) 病情严重程度的关系及其在AECOPD严重程度中的诊断价值。方法 选取2016年11月至2017年2月在甘肃省人民医院呼吸科住院的AECOPD患者40例,并以同期健康体检者20例作为对照。收集AECOPD患者就诊当天及治疗缓解后出院前天空腹检测的超敏C反应蛋白(hsCRP)、降钙素原(PCT)值,应用酶联免疫吸附法(ELISA)检测入组当天及治疗后出院前天血清钙结合蛋白S100A12水平。结果 AECOPD组治疗前血清钙结合蛋白S100A12水平显著高于治疗后(P<0.05),且高于健康对照组(P<0.05);AECOPD组治疗前血清钙结合蛋白S100A12水平与hsCRP、PCT呈正相关(r=0.414,P<0.01; r=0.326,P<0.05),治疗后与hsCRP、PCT无相关性。结论 钙结合蛋白S100A12水平可用作AECOPD病情严重程度的评估及诊断指标。

关键词: 肺疾病, 慢性阻塞性, 钙结合蛋白质类, C反应蛋白质, 降钙素

Abstract: Objective  To investigate the relationship between serum calcium binding protein S100A12 level and the severity of chronic obstructive pulmonary disease in acute exacerbation(AECOPD) and its diagnostic value. Methods  From November 2016 to February 2017, 40 patients with AECOPD hospitalized were enrolled and 20 healthy subjects were enrolled as controls. The hsCRP and procalcitonin (PCT) values of  AECOPD patients on the day of treatment and on the day before discharge hsCRP  were collected. The level of serum calcium binding protein S100A12 was detected by enzymelinked immunosorbent assay (ELISA). Results  Before treatment, the serum level of S100A12 in AECOPD group was significantly higher than that in healthy controls (P<0.05), and after treatment, the serum level of S100A12 in AECOPD group was significantly lower than that in healthy controls (P<0.05) . Before treatment, the level of S100A12 in AECOPD group showed a positive correlation with hsCRP and PCT(r=0.414,P<0.01;  r=0.326,P<0.05). There was no correlation between S100A12, hsCRP and PCT after treatment. Conclusion  The level of calcium binding protein S100A12 can be used as an indicator in AECOPD severity assessment and diagnosis.

Key words: pulmonary disease, chronic obstructive, calciumbinding proteins, Creactive protein, calcitonin